Notable Labs, Ltd. (NTBL)

1.5095 +0.3195 (+26.86%) As of 11:10AM EDT. Market open.

Notable Labs, Ltd.

320 Hatch Drive
Foster City, CA 94404
United States
415-851-2410
https://www.notablelabs.com

Sector(s): Healthcare
Industry: Biotechnology
Full-time employees: 16

Key executives

Name	Title	Pay	Exercised	Year born
Dr. Thomas A. Bock M.B.A., M.D.	CEO & Director	508.82k	N/A	1965
Mr. Scott Alan McPherson CFE, CPA, CVA	Chief Financial Officer	412.89k	N/A	1961
Dr. Joseph P. Wagner Ph.D.	Chief Scientific Officer	424.88k	N/A	1968
Dr. Glenn C. Michelson M.D.	Chief Medical Officer	N/A	N/A	N/A

Amounts are as of 31 December 2023, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Notable Labs, Ltd., a clinical-stage platform therapeutics company, engages in developing predictive precision medicines for patients with cancer. The company, through its proprietary Predictive Precision Medicines Platform (PPMP), bio-simulates a cancer treatment and predicts, whether or not the patient will clinically respond to their actual treatment. Its PPMP is designed to identify and select clinically responsive patients prior to their treatment and thus fast-track therapeutic development in this patient population. The company's pipeline includes Volasertib, a potent Polo-like kinase 1 (PLK-1) inhibitor to induce cell cycle arrest and apoptosis in various cancer cells.; and Fosciclopirox, a pro-drug of ciclopirox for AML. Notable Labs, Ltd. was incorporated in 2014 and is headquartered in Foster City, California.

Corporate governance

Notable Labs, Ltd.’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.